- Home
- ZBIO vs CGTL Comparison
ZBIO vs CGTL Comparison
Compare ZBIO & CGTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- CGTL
- Stock Information
- Founded
- ZBIO 2019
- CGTL 2016
- Country
- ZBIO United States
- CGTL Hong Kong
- Employees
- ZBIO N/A
- CGTL N/A
- Industry
- ZBIO
- CGTL
- Sector
- ZBIO
- CGTL
- Exchange
- ZBIO NYSE
- CGTL NYSE
- Market Cap
- ZBIO 339.3M
- CGTL 152.2M
- IPO Year
- ZBIO 2024
- CGTL 2024
- Fundamental
- Price
- ZBIO $8.12
- CGTL $5.65
- Analyst Decision
- ZBIO Strong Buy
- CGTL
- Analyst Count
- ZBIO 5
- CGTL 0
- Target Price
- ZBIO $31.75
- CGTL N/A
- AVG Volume (30 Days)
- ZBIO 458.9K
- CGTL 98.5K
- Earning Date
- ZBIO 02-16-2025
- CGTL 02-15-2025
- Dividend Yield
- ZBIO N/A
- CGTL N/A
- EPS Growth
- ZBIO N/A
- CGTL N/A
- EPS
- ZBIO N/A
- CGTL 0.14
- Revenue
- ZBIO N/A
- CGTL $42,953,944.00
- Revenue This Year
- ZBIO N/A
- CGTL N/A
- Revenue Next Year
- ZBIO N/A
- CGTL N/A
- P/E Ratio
- ZBIO N/A
- CGTL $41.13
- Revenue Growth
- ZBIO N/A
- CGTL N/A
- 52 Week Low
- ZBIO $7.50
- CGTL $3.37
- 52 Week High
- ZBIO $26.25
- CGTL $10.59
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- CGTL N/A
- Support Level
- ZBIO N/A
- CGTL N/A
- Resistance Level
- ZBIO N/A
- CGTL N/A
- Average True Range (ATR)
- ZBIO 0.00
- CGTL 0.00
- MACD
- ZBIO 0.00
- CGTL 0.00
- Stochastic Oscillator
- ZBIO 0.00
- CGTL 0.00
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About CGTL CREATIVE GLOBAL TECHNOLOGY HOLDINGS LIMITED
Creative Global Technology Holdings Ltd Conducts its business through its subsidiary, which is a Hong Kong-based company sourcing and reselling recycled consumer electronic devices, currently mostly smartphones, tablets, and laptops.